Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKIN ELEMENTS LIMITED Capital/Financing Update 2023

May 2, 2023

65803_rns_2023-05-02_690c45d5-51a3-4c7d-a66f-39ae8016c80f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [596 x 190] intentionally omitted <==

3 May 2023

SKIN EXTENDS NON-RENOUNCEABLE ENTITLEMENT ISSUE OFFER TO SHAREHOLDERS

Australian biotechnology company Skin Elements Limited (ASX:SKN) (SKN, the Company) wishes to advise that the closing date for its Entitlement Issue Prospectus, dated 5[th] April 2023 for an entitlement issue of one share for every five fully paid ordinary shares together with one free new option for every share applied has been extended to 5pm (AWST) Monday 22[nd] May 2023.

The Company has corresponded with a number of shareholders who are interested in participating in the Offer but have experienced delays in the receipt via post of their Offer Documents.

The Board has resolved to extend the closing date by two weeks from today, to allow all eligible shareholders the opportunity to participate. This will be the only extension to the Offer Period.

If you have not received the Prospectus, please email our Share Registry at [email protected].

If you have any questions about the terms of the Offer or how to accept, please call the Skin Entitlement Offer Information Line on +61 8939 8033.

Revised dates for the Entitlement Offer:

EVENT DATE
Closing Date (5.00pm AWST) 22 May 2023
Issue date and Announcement of results and lodgement of 29 May 2023
Appendix 2A
Date trading starts on normal T+2 basis 30 May 2023
First settlement date of trades conducted on a +deferred 1 June 2023
settlement basis and on normal T+2 basis

This ASX announcement has been authorised for release by the Board.

ENDS

For further information, please contact:
Peter Malone Media and Investor Inquiries
Executive Chairman James Moses
Skin Elements Limited Mandate Corporate
T: +61 439 430 770 T: +61 420 991 574
E: [email protected] E:
[email protected]

About Skin Elements

Skin Elements (ASX: SKN) is an award winning Australian owned and operated ASXlisted biotechnology healthcare company focused on the commercialisation of the anti-microbial SE Formula[TM] through a range of natural and organic health care products. Skin Elements innovative approach to plant-based and organic personal care and skincare products has enabled the creation of a portfolio of products that have been sold and distributed across the world. Its flagship products include the SuprCuvr TGA-registered, hospital-grade plant-based disinfectant, Eco Nurture plant biostimulant, Invisi Shield alcohol free natural sanitiser, TGA registered Soléo Organics natural and organic sunscreen, TGA registered PapayaActivs natural therapeutics skincare and Elizabeth Jane Natural Cosmetics brand.

Further information is available via the Company website: www.skinelementslimited.com and on the Company online store: www.sknlife.com.au

==> picture [596 x 138] intentionally omitted <==